These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9736189)

  • 1. Geneticization: the Cyprus paradigm.
    Hoedemaekers R; ten Have H
    J Med Philos; 1998 Jun; 23(3):274-87. PubMed ID: 9736189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic screening and ethics: European perspectives.
    Chadwick R; ten Have H; Husted J; Levitt M; McGleenan T; Shickle D; Wiesing U
    J Med Philos; 1998 Jun; 23(3):255-73. PubMed ID: 9736188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problems in the control of genetic disorders.
    Kuliev AM; Modell B
    Biomed Sci; 1990 Jan; 1(1):3-17. PubMed ID: 2130914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monitoring pregnant patients from risk countries with sickle cell disease and thalassemia. Clinical aspects, screening and prenatal diagnosis].
    Dickerhoff R; Kulozik AE; Kohne E
    Geburtshilfe Frauenheilkd; 1993 Apr; 53(4):215-21. PubMed ID: 8491363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the national health policy of thalassaemia screening in the Islamic Republic of Iran.
    Ghotbi N; Tsukatani T
    East Mediterr Health J; 2005 May; 11(3):308-18. PubMed ID: 16602449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of homozygous beta thalassemia by premarital screening and prenatal diagnosis in India.
    Tamhankar PM; Agarwal S; Arya V; Kumar R; Gupta UR; Agarwal SS
    Prenat Diagn; 2009 Jan; 29(1):83-8. PubMed ID: 19090545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premarital screening for beta-thalassaemia in Southern Iran: options for improving the programme.
    Karimi M; Jamalian N; Yarmohammadi H; Askarnejad A; Afrasiabi A; Hashemi A
    J Med Screen; 2007; 14(2):62-6. PubMed ID: 17626703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sociocultural challenges of beta-thalassaemia major birth in carriers of beta-thalassaemia in Iran.
    Haghpanah S; Nasirabadi S; Rahimi N; Faramarzi H; Karimi M
    J Med Screen; 2012 Sep; 19(3):109-11. PubMed ID: 23093727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cyprus Thalassemia Control Program.
    Angastiniotis M; Kyriakidou S; Hadjiminas M
    Birth Defects Orig Artic Ser; 1988; 23(5B):417-32. PubMed ID: 3390571
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of beta-thalassemia major and Hb Bart's hydrops fetalis syndrome.
    Beris P; Darbellay R; Extermann P
    Semin Hematol; 1995 Oct; 32(4):244-61. PubMed ID: 8560282
    [No Abstract]   [Full Text] [Related]  

  • 12. The experience of beta-thalassaemia and its prevention in Cyprus.
    Kalokairinou EM
    Med Law; 2007 Jun; 26(2):291-307. PubMed ID: 17639852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of thalassemia in Songklanagarind Hospital in southern Thailand.
    Kor-anantakul O; Suwanrath CT; Leetanaporn R; Suntharasaj T; Liabsuetrakul T; Rattanaprueksachart R
    Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):795-800. PubMed ID: 10772567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes towards prenatal diagnosis and termination of pregnancy for thalassaemia in pregnant Pakistani women in the North of England.
    Ahmed S; Green JM; Hewison J
    Prenat Diagn; 2006 Mar; 26(3):248-57. PubMed ID: 16475227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-thalassaemia mutations and the underlying beta gene cluster haplotypes in the Greek population.
    Kollia P; Karababa PH; Sinopoulou K; Voskaridou E; Boussiou M; Papadakis M; Loukopoulos D
    Gene Geogr; 1992; 6(1-2):59-70. PubMed ID: 1299316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of genetic counselling in prenatal diagnosis of β-thalassaemia in Pakistan.
    Bozdar M; Ahmed S; Jamy OH; Bin Hanif T; Ali N; Khan Khattak SA
    J Coll Physicians Surg Pak; 2013 Aug; 23(8):553-7. PubMed ID: 23930870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis of beta-thalassemia in Southern Punjab, Pakistan.
    Baig SM; Azhar A; Hassan H; Baig JM; Aslam M; Ud Din MA; Qureshi JA; Zaman T
    Prenat Diagn; 2006 Oct; 26(10):903-5. PubMed ID: 16821247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of thalassemia in Cyprus.
    Angastiniotis M
    Birth Defects Orig Artic Ser; 1992; 28(3):38-43. PubMed ID: 1489955
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of a national beta-thalassemia carrier screening program on the birth rate of thalassemia major.
    Chern JP; Lin KH; Su YN; Lu MY; Jou ST; Lin DT; Wang SC; Lin KS
    Pediatr Blood Cancer; 2006 Jan; 46(1):72-6. PubMed ID: 16206199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of discriminant functions in screening for beta-thalassaemia traits during pregnancy.
    Yeo GS; Tan KH; Liu TC
    Singapore Med J; 1995 Dec; 36(6):615-8. PubMed ID: 8781633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.